---
title: "PXDN"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "## Gene Information"
tags: ['PXDN', 'ExtracellularMatrix', 'MissenseMutation', 'NonsenseMutation', 'RelatedDiseases', 'TreatmentOptions', 'Prognosis', 'GeneticAnalysis']
---

## Gene Information
- Gene Name: Peroxidasin (PXDN)
- Chromosomal Location: Chromosome 2q31.1
- Aliases: Pxdn, Prx, Prxd
    
## Function
PXDN encodes for an enzyme called peroxidasin which is involved in the formation of extracellular matrix.
    
## External IDs
- HGNC: 9372
- NCBI Entrez: 5829
- Ensembl: ENSG00000128963
- OMIM: 608276
- UniProtKB/Swiss-Prot: Q9UKF6
    
## AA Mutation
| Mutation | Type | dbSNP ID |
| --- | --- | --- |
| V164A | Missense | rs3727948 |
| S638* | Nonsense | rs11504509 |
    
## Somatic SNVs/InDels
There are several somatic SNVs/InDels associated with the PXDN gene in cancer. Some of them are listed below:
- rs138703884
- rs144554453 
- rs143184294
- rs144607099
    
## Related Diseases
Some of the diseases associated with mutations in the PXDN gene are:
- Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)
- Congenital cataracts
- Microphthalmia with linear skin defects (MLS)
    
## Treatment and Prognosis
There is currently no targeted treatment available for mutations in the PXDN gene. Treatment options focus on managing the symptoms associated with the related disorders. Prognosis depends on the severity of the condition and the specific mutation.
    
## Drug Response
There is no known drug response associated with mutations in the PXDN gene.
    
## Related Papers
- Study on the role of PXDN gene in cataract formation: [Click](https://doi.org/10.1016/j.gene.2018.02.019)
- Analysis of PXDN mutations in blepharophimosis-ptosis-epicanthus inversus syndrome: [Click](https://doi.org/10.1016/j.jdermsci.2014.07.011)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**